The clinician’s guide to prevention and treatment of osteoporosis M. S. LeBoffS. L. GreenspanE. S. Siris Consensus Statement Open access 28 April 2022 Pages: 2049 - 2102
Update of the fracture risk prediction tool FRAX: a systematic review of potential cohorts and analysis plan L. VandenputH. JohanssonJ. A. Kanis Review 31 May 2022 Pages: 2103 - 2136
Global, regional prevalence, and risk factors of osteoporosis according to the World Health Organization diagnostic criteria: a systematic review and meta-analysis P.-L. XiaoA.-Y. CuiH.-D. Lu Review 10 June 2022 Pages: 2137 - 2153
Baseline bone turnover marker levels can predict change in bone mineral density during antiresorptive treatment in osteoporotic patients: the Copenhagen bone turnover marker study S. E. BønløkkeM. S. RandN. R. Jørgensen Original Article 21 June 2022 Pages: 2155 - 2164
Effects of odanacatib on bone-turnover markers in osteoporotic postmenopausal women: a post hoc analysis of the LOFT study L. T. DuongS. ClarkS. A. Stoch Original Article 17 June 2022 Pages: 2165 - 2175
Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study Tobias RuppEmil von VopeliusTim Rolvien Original Article Open access 25 June 2022 Pages: 2177 - 2184
Montreal cognitive assessment (MoCA) is highly correlated with 1-year mortality in hip fracture patients R. M. Y. WongR. W. K. NgW.-H. Cheung Original Article 28 June 2022 Pages: 2185 - 2192
Na-Cl Co-transporter (NCC) gene inactivation is associated with improved bone microstructure Wenting QiZinan YinWeibo Xia Original Article 29 June 2022 Pages: 2193 - 2204
Real-world evaluation of osteoporotic fractures using the Japan Medical Data Vision database Saeko FujiwaraAmy Buchanan-HughesHong Li Original Article 02 July 2022 Pages: 2205 - 2216
Surgical treatment for fragility hip fractures during the COVID-19 pandemic resulted in lower short-term postoperative functional outcome and a higher complication rate compared to the pre-pandemic period Chirathit AnusitviwatEkasame VanitcharoenkulAasis Unnanuntana Original Article Open access 09 July 2022 Pages: 2217 - 2226
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone Rimesh PalSanjay Kumar Bhadada Letter to the Editor 01 July 2022 Pages: 2227 - 2228
Letter to the editor Wojciech PluskiewiczFranciszek Pietraszkiewicz Letter to the Editor 04 August 2022 Pages: 2229 - 2230
Response to letter to the editor, regarding “The association between hyperkyphosis and fall incidence among community-dwelling adults” Marije C. KoeléHanna C. WillemsNathalie van der Velde Letter to the Editor 04 August 2022 Pages: 2231 - 2232
Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association? Ilaria MormileRoberta RussoDomenico Rendina Letter to the Editor Open access 19 August 2022 Pages: 2233 - 2235
Osteogenesis imperfecta and rheumatoid arthritis: connective issues Laura Otilia DamianDiana MicleaAlexandra Crăciun Letter to the Editor 19 August 2022 Pages: 2237 - 2239
Correction: Elevated blood pressure, antihypertensive medications and bone health in the population: revisiting old hypotheses and exploring future research directions D. CanoyN. C. HarveyK. Rahimi Correction Open access 23 August 2022 Pages: 2241 - 2241
Correction to: The clinician’s guide to prevention and treatment of osteoporosis M. S. LeBoffS. L. GreenspanE. S. Siris Correction Open access 28 July 2022 Pages: 2243 - 2243
